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Available online 23 October 2018Antiplasmodial, antitrypanosomal and anti-HIV-1 activities of crude extracts, fractions and some isolated com-
pounds from two Cameroonianmedicinal plants: Antrocaryon klaineanum Pierre (Anacardiaceae) and Diospyros
conocarpaGürke ex K. Schum. (Ebenaceae) were assessed. The phytochemical studies led to the isolation of eight
compounds (1–8) from Diospyros conocarpa and six compounds (6, 9–13) from Antrocaryon klaineanum. These
compounds were identiﬁed as mangiferolic acid (1), 3β, 22(S)-dihydroxycycloart-24E-en-26-oic acid (2), lupeol
(3), aridanin (4), betulin (5), betulinic acid (6), bergenin (7), D-quercitol(8), entilinC(9), entilin A(10), antrocarine
A(11), 7R,20(S)-dihydroxy-4,24(28)-ergostadien-3-one(12) andstigmasterol glucoside (13). The criteria for activ-
itywere set as follows: an IC50 value b10 μg/mL for crude extracts and b1 μg/mL for pure compounds. The hexane/
ethyl acetate (1:1) fraction of A.klaineanum root bark (AKERF1) and the hexane/ethyl acetate (1:1) fraction of A.
klaineanum trunk bark (AKETF1) presented the strongest antiplasmodial activities with IC50 values of 0.4 and 4.4
μg/mL, respectively. Aridanin (4) and antrocarine A(11), as well as the crude extract ofD.conocarpa roots (EDCR),
AKERF1 and AKETF1 showedmoderate trypanocidal effects. The crude extract of A.klaineanum root bark (AKER)
andAKETF1 exhibited attractive activitiesonHIV-1 integrasewith IC50 values of 1.96 and24.04 μg/mL, respectively.
Theresultsprovidebaseline informationontheuseofA.klaineanumandD.conocarpaextracts,aswellascertaincom-
ponents, as sources of new antiplasmodial, antitrypanosomal and anti-HIV drugs.
© 2018 SAAB. Published by Elsevier B.V. All rights reserved.Keywords:
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Nowadays, parasitic diseases continue to be a threat to public health.
In particular, two of these diseases cause serious mortality and morbid-
ity in humans, the African trypanosomiasis or sleeping sickness, caused
by Trypanosoma brucei, and the malaria, transmitted by Plasmodium
species, of which the deadliest is Plasmodium falciparum. With the in-
crease in the resistance of P.falciparum to several chemotherapeuticela, Department of Biological
s (FMPS), University of Douala,
nkela), azebaze@yahoo.com
ghts reserved.agents (Wellems and Plowe, 2001), malaria remains an important
health concern in many countries, particularly in Africa.
Futhermore, acquired immunodeﬁciency syndrome (AIDS), caused
by human immunodeﬁciency virus type-1 (HIV-1), is still a serious
threat to public health, with more than 35 million people infected
worldwide (WHO, 2017). The African continent, and more particularly
sub-SaharanAfrica, is the most affected region, accounting for almost
two thirds of the global total of newHIV-1 infections. In theﬁght against
AIDS, inhibition of the HIV-1 integrase (IN) activity effectively sup-
presses virus replication, resulting in sustained clinical efﬁcacy. How-
ever, only a few HIV-1IN inhibitors are currently approved for clinical
use (Pandey and Grandgenett, 2008). Searching for other IN inhibitors
from natural sources could be a useful approach (Suedee et al., 2014).
Indeed, plant biodiversity and knowledge of traditional healing can
potentially openup newavenues in theﬁeld of drug discovery, as exem-
pliﬁed by the successful case of artemisinin. Here, we investigated the
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uses and bibliographical studies, namely Antrocaryon klaineanum Pierre
(Anacardiaceae) and Diospyros conocarpa Gürke ex K. Schum.
(Ebenaceae).
Antrocaryon klaineanum is recommended in traditional medicine to
treat chlamydiae infections, wounds, back pain, liver diseases and fe-
male sterility (Betti, 2002; Matig et al., 2006). In Gabon, the powdered
bark is used to cure liver complaints and to facilitate the production of
breast milk, while the roots are used to treat abdominal and liver com-
plaints (Kémeuzé and Nkongmeneck, 2011).
A chemical investigation of the stembark of A.klaineanumwas under-
taken and resulted in the characterization of six new sterols (Douanla
et al., 2015) and the isolation of two known compounds, 7,20S-
dihydroxyergosta-4,24(28)-dien-3-one(Tchouankeu et al., 1996) and
20S-hydroxyergosta-4,6,24(28)-trien-3-one, described previously in
the literature as a semi-synthetic product (Roy et al., 1982). The
antiplasmodial assays of A.klaineanum crude extract and its isolated com-
pounds were also reported (Douanla et al., 2015), and recently we puri-
ﬁed and characterized eight compounds, resulting in the isolation of a
new derivative (Fouokeng et al., 2017). Finally, invitroanti-HIV activity
has also been reported for plants of Anacardiaceae family (Rhus
parviﬂora, Rhus succedanea…) (Lin et al., 1997; Modi et al., 2013).
Plants of the genusDiospyros are used in traditional medicine for the
treatment of several ailments such as leprosy, skin eruptions, eye infec-
tions, cough, fever, diarrhea, dysentery, malaria and skin diseases
(Mallavadhani et al., 1998; Pathak et al., 2004; Ganapaty et al., 2006;
Maridass, 2008; Sinha and Bansal, 2008; Sutthivaiyakit et al., 2012;
Choi et al., 2015). This plant family is likewise used in the treatment of
parasitic diseases, more especially those transmitted by protozoa
(Freiburghaus et al., 1997; Mallavadhani et al., 1998; Bizimana et al.,
2006; Norhayati et al., 2013).
Previous phytochemical studies on the genus Diospyros resulted in
the isolation of various classes of secondary metabolites including
triterpenes, naphthoquinones, coumarins and phenolic glycosides
(Maridass, 2008; Sinha and Bansal, 2008). Limited information is
known about the chemical constituents of D.conocarpa. Only seven
compounds have been isolated and characterized from the stem bark
of this plant (Feusso et al., 2016). Finally, in modern medicine various
metabolites from Diospyros species have shown potent inhibitory activ-
ity against HIV-I protease, such as ursolic acid, whereas other com-
pounds from this genus, such as beta-amyrin, betulin or diospyrin,
exhibit moderate to potent cytotoxic actions on different carcinoma
models (Sinha and Bansal, 2008).
In the present work, we carried out investigations on the
antitrypanosomal, antimalarial andanti-HIVactivitiesof thecrudeextract
and isolatedcompounds fromthetwoplants. Inaddition, cytotoxicitywas
evaluated to determine the selectivity/speciﬁcity of the plant samples.
2. Materials and methods
2.1. Plant materials
The trunk and root bark of A.klaineanum were collected on mount
Eloumden in the central region of Cameroon in November 2014. The
trunkand leaves ofD.conocarpawere collected atNtouessong in the cen-
tral region inApril 2013,whereas therootswere collectedatNkoemvone
in the southern region in January 2015. The plant identiﬁcation was
carried out by the members of the National Herbarium of Cameroon,
where voucher specimens were deposited (No 21247SRF/CAM and
24,030/SRF/CAM for A. klaineanum and D.conocarpa, respectively).
2.2. Extraction and isolation
2.2.1. Extraction and isolation from D.conocarpa
The different parts ofD.conocarpa (leaves, trunk and roots)were air-
dried at ambient temperature, then grounded and extracted at roomtemperature with methanol for 48 h. The extracts were concentrated
in a rotary evaporator to provide 210.8, 300.0, and 123.2 g of crude ex-
tracts from 1.6, 8.5 and 2.4 kg of leaves, trunk and roots, respectively.
The total amounts of the three extracts were used for further separa-
tions and biological tests.
The leaf extract (EDCF) was separated by chromatography on silica
gel eluted with a n-Hex, a n-Hex/EtOAc gradient of increasing polarity
and ﬁnally MeOH to yield four fractions: A(5.01 g), B(94.8 g), C(7.4 g)
and D(35.6 g). Non-polar fraction A and polar fractions C and D have
not been studied here. Fraction Bwas further subjected to silica gel col-
umn chromatography eluted with an n-Hex/EtOAc gradient of increas-
ing polarity. Elution with an n-Hex/EtOAc (7:1) gave 1(30.0 mg) and
with n-Hex/EtOAc (7:3) 2(38.2 mg).
The trunk (EDCTr) and roots (EDCR) extractswere subjected to silica
gel column chromatography eluted with a mixture of n-Hex/ EtOAc,
pure ethyl acetate and a mixture of EtOAc/ MeOH. Elution of EDCTr ex-
tract with n-Hex/EtOAc (39:1) gave 3(10.1mg), andwith EtOAc/MeOH
(19:1) gave 4(30.2mg). For the EDCR extract, elutionwith n-Hex/EtOAc
(37:3) led to the isolation of 5(9.4 mg) while 6(12.5 mg) was isolated
using n-Hex/EtOAc (9:1). Pure ethyl acetate was used to isolate
7(23.5 mg) and 8(918.0 mg) was isolated with EtOAc/MeOH (19:1).
2.2.2. Extraction and isolation from A.klaineanum
2.2.2.1. Extraction and isolation from trunk bark. The air-dried and pow-
dered trunk bark of A.klaineanum (AKET) (8.5 kg) was extracted twice
with methanol at room temperature for 48 h. After evaporation with a
rotary evaporator under reduced pressure at 40 °C, 833.4 g of crude ex-
tract was obtained andwas fractionated using vacuumchromatography
into fractionsA [hexane/ethyl acetate (1:0 and 1:1), 84.5 g], B [ethyl ac-
etate, 48.7 g] and C [methanol, 638.2 g]. FractionsB and C have not been
studied yet.
Fraction A (AKETF1) (84.5 g) was subjected to silica gel column
chromatography and eluted with a gradient system of n-hexane/
EtOAc (1:0 to 0:1); 475 sub-fractions(100 mL each) were collected
and pooled on the basis of their TLC proﬁle. Sub-fractions 32–101 ob-
tained by eluting the column with n-hexane/EtOAc (97.5:2.5) afforded
9(236.6 mg) and 10(452.3 mg). Sub-fractions 102–205 (6.9 g) obtained
by eluting the column with n-hexane/EtOAc (95:5 and 9:1) were fur-
ther chromatographed on silica gel column and eluted with a gradient
of n-hexane/EtOAc (0:1 to 8:2) to give 6(237 mg). Elution with n-hex-
ane/EtOAc (8:2) (232–254 sub-fractions) gave 11(63 mg) and
12(108 mg). Finally, 13(104 mg) was obtained from sub-fractions
406–460 using elution with n-hexane/EtOAc (1:1).
2.2.2.2. Extraction and isolation from root bark. The air-dried and pow-
dered root bark of A.klaineanum (AKER) (7.5 kg) was extracted twice
with methanol at room temperature for 48 h. After evaporation with a
rotary evaporator under reduced pressure at 40 °C, 435.5 g of crude ex-
tract was obtained andwas fractionated using vacuumchromatography
into fractions A [hexane/ethyl acetate (1:0 and 1:1), 20.40 g], B [ethyl
acetate, 170.35 g] and C [methanol, 180.25 g]. Only the fraction A
(AKERF1) has been tested here.
2.3. Compound identiﬁcation
The isolated compounds were characterized using various spectro-
scopic and spectrometric techniques such as 1D/2D-Nuclear Magnetic
Resonance spectroscopy (NMR) andmass spectrometry (MS). The opti-
cal rotations were measured with a Perking–Elmer polarimeter (model
241) at the sodium D line (λ= 589 nm). Melting points were deter-
mined on a Melter FP61 melting point apparatus. The IR spectra were
recorded on a FT/IR-4100 Jasco spectrometer. UV/Vis spectra were ob-
tained on a Jasco V-650 spectrophotometer. The NMR spectra were re-
corded on a Varian Inova-600NMR spectrometer at 600 MHz (1H
NMR) or 150 MHz (13C NMR). Chemical shifts were given in δ values
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tra were obtained on a Bruker TOF LC–MS spectrometer. Open column
chromatography was performed with silica gel (70–230 mesh). Thin-
layer chromatography (TLC) was carried out on precoated silica gel
60 F254 plates (Merck), and the TLC spots were viewed at 254 nm
and visualized by heating the plates at 80 °C for 10 min after spraying
with 50% aqueous sulfuric acid.
2.4. Physico-chemical properties of isolated compounds
Mangiferolic acid(1): white powder, ESI-MS: [M-H]− 455.4. 13C
NMR: 32.0 C-1; 30.4 C-2; 77.4 C-3; 40.4 C-4; 47.1 C-5; 21.1 C-6; 26.0
C-7; 47.8 C-8; 19.7 C-9; 26.1 C-10; 26.3 C-11; 32.1 C-12; 45.3 C-13;
48.8 C-14; 35.4 C-15; 26.1 C-16; 52.6 C-17; 18.2 C-18; 29.7 C-19; 36.1
C-20; 19.4 C-21; 34.8 C-22; 25.9 C-23; 125.8 C-24; 146.1 C-25; 169.6
C-26; 12.6 C-27; 18.2 C-28; 14.5 C-29; 19.3 C-30. 1H NMR(300 MHz;
CDCl3): 1.28 (m)H-1; 1.77 (m)H-2; 3.28 (m)H-3; 1.32 (m)H-5; 1.61
(m)H-6; 1.30 (m)H-7;H-8; 1.20 (m)H-11; 1.63 (m)H-12; 1.35 (m)H-
15; 1.10 (m)H-16; 1.64 (m)H-17; 0.98 (s)H-18; 0.32 (d, J = 4.2); 0.56
(d, J = 4.2) H-19; 1.30 (m)H-20; 0.94 (d, J = 7.2) H-21; 1.60 (m)H-
22; 1.37 (m)H-23; 6.89 (t, J = 6.6; 1.2) H-24; 1.81 (s)H-27; 0.63 (s)H-
28; 0.83 (s)H-29; 0.98 (s)H-30.
3β,22(R)-dihydroxycycloart-24E-en-26-oic acid(2): white pow-
der, ESI-MS: [M-H]− 471.4. 13C NMR: 33.4 C-1; 31.3 C-2; 78.0 C-3;
41.1 C-4; 47.5 C-5; 21.5 C-6; 28.6 C-7; 48.1 C-8; 20.1 C-9; 26.2 C-10;
26.6 C-11; 32.9 C-12; 45.8 C-13; 49.2 C-14; 35.8 C-15; 26.3 C-16; 53.3
C-17; 19.6 C-18; 29.9 C-19; 44.1 C-20; 14.9 C-21; 65.8 C-22; 26.8 C-
23; 127.3 C-24; 146.6 C-25; 170.8 C-26; 13.2 C-27; 18.4 C-28; 26.6 C-
29; 26.2 C-30. 1H NMR(300 MHz; CDCl3): 1.28(m)H-1; 1.76 (m)H-2;
3.56 (m)H-3; 1.31 (m)H-5; 1.61 (m)H-6; 1.30 (m)H-7; 1.53 (m)H-8;
1.20 (m)H-11; 1.63 (m)H-12; 1.35 (m)H-15; 1.10 (m)H-16; 1.64 (m)
H-17; 1.06 (s)H-18; 0.32 (d, J = 4.1); 0.58 (d, J = 4.1) H-19; 1.30 (m)
H-20; 0.91 (d, J = 7.2) H-21; 4.98 (t, J = 3.7) H-22; 1.35 (m)H-23;
7.51 (d, J = 6.7) H-24; 2.08 (s)H-27; 1.11 (s)H-28; 0.98 (s)H-29; 1.04
(s)H-30.
Lupeol(3): white ﬁber, ESI-MS: [M+ Na]+ 449.4. 13C NMR: 38.7 C-
1; 27.4 C-2; 79.0 C-3; 38.8 C-4; 55.3 C-5; 18.3 C-6; 34.3 C-7; 40.8 C-8;
50.4 C-9; 37.1 C-10; 20.9 C-11; 25.1 C-12; 38.0 C-13; 42.8 C-14; 27.4
C-15; 35.6 C-16; 43.0 C-17; 48.0 C-18; 48.3 C-19; 151.6 C-20; 29.7 C-
21; 40.0 C-22; 28.0 C-23; 15.3 C-24; 15.9 C-25; 16.1 C-26; 14.5 C-27;
18.0 C-28; 109.3 C-29; 19.3 C-30.
Aridanin(4): white powder, ESI-MS: [M-H]− 658.5. 13C NMR: 38.6
C-1; 26.4 C-2; 89.2 C-3; 39.3 C-4; 55.8 C-5; 18.6 C-6; 33.2 C-7; 39.8 C-
8; 48.0 C-9; 37.0 C-10; 23.7 C-11; 122.6 C-12; 144.8 C-13; 42.2 C-14;
28.3 C-15; 23.8 C-16; 46.7 C-17; 42.0 C-18; 46.5 C-19; 31.0 C-20; 34.3
C-21; 33.3 C-22; 28.2 C-23; 17.0 C-24; 15.4 C-25; 17.4 C-26; 26.2 C-
27; 180.1 C-28; 33.3 C-29; 23.7 C-30; 104.8 C-1′; 58.2 C-2′; 76.1 C-3′;
72.8 C-4′; 78.2 C-5′; 63.1 C-6′. 1H NMR(300 MHz; pyridin-d5): 1.20
(m); 0.82 (t)H-1; 2.09 (m); 1.72 (m)H-2; 3.23 (m)H-3; 0.76 (s)H-5;
1.25 (m); 1.15 (m)H-6; 1.15 (m); 1.24 (m)H-7; 1.62 (t)H-9; 1.83 (d);
1.87 (d)H-11; 5.50 (sl) H-12; 2.07 (m)H-15; 2.04 (t)H-16; 3.23 (m)H-
18; 1.15 (m); 1.82 (m)H-19; 1.12 (d); 1.24 (d)H-21; 1.82 (m); 2.00
(t)H-22; 1.11 (s)H-23; 0.98 (s)H-24; 0.76 (s)H-25; 0.97 (s)H-26; 1.15
(s)H-27; 0.95 (s)H-29; 1.01 (s)H-30; 5.04 (d, J = 8.2) H-1′; 4.26 (m)
H-2′; 4.22 (t; J = 9) H-3′; 4.08 (t; J = 9 Hz) H-4′; 3.95 (m)H-5′; 4.18
(m); 4.38 (m)H-6′; 2.07 (s)OCH3; 8.82 (d, J = 9) NHCOOCH3.
Betulin(5): white powder, ESI-MS: [M+ H]+ 443.4. 13C NMR: 38.8
C-1; 27.4 C-2; 79.0 C-3; 38.9 C-4; 55.3 C-5; 18.3 C-6; 34.3 C-7; 41.0 C-8;
50.4 C-9; 37.4 C-10; 20.9 C-11; 25.3 C-12; 37.2 C-13; 42.8 C-14; 27.1 C-
15; 29.2 C-16; 47.8 C-17; 47.8 C-18; 48.8 C-19; 150.5 C-20; 29.8 C-21;
34.0 C-22; 28.0 C-23; 16.1 C-24; 16.3 C-25; 16.3 C-26; 16.1 C-27; 60.6
C-28; 109.7 C-29; 19.1 C-30.
Betulinic acid(6): white powder, ESI-MS: [M + Na]+ 479.4. 13C
NMR: 39.0 C-1; 27.6 C-2; 78.2 C-3; 39.0 C-4; 55.5 C-5; 18.4 C-6; 34.5
C-7; 40.8 C-8; 50.7 C-9; 37.3 C-10; 21.0 C-11; 25.6 C-12; 38.2 C-13;
42.5 C-14; 30.4 C-15; 32.6 C-16; 56.3 C-17; 47.1 C-18; 49.4 C-19;150.0 C-20; 29.9 C-21; 37.3 C-22; 27.9 C-23; 15.4 C-24; 16.2 C-25;
16.3 C-26; 14.6 C-27; 180.6 C-28; 108.8 C-29; 19.6 C-30.
Bergenin(7): colorless powder, ESI-MS: [M-H]− 327.4. 13C NMR:
164.3 C-2; 119.5 C-3; 111.1 C-4; 152.7 C-5; 141.9 C-6; 149.3 C-7;
116.6 C-8; 73.9 C-9; 83.5 C-11; 72.1 C-12; 75.5 C-13; 81.3 C-14; 60.2
C-15; 62.6 C-16. 1H NMR(300 MHz; pyridin-d5): 7.75 (s)H-4; 5.12 (d, J
= 10 Hz) H-9; 4.12 (s)H-11; 4.43 (t, J = 9.5; 10 Hz) H-12; 4.60 (t, J
= 10.7; 2.5 Hz) H-13; 4.70 (dd, J = 9.5; 8.5 Hz) H-14; 3.96 (s)H-15;
4.09 (m)H-16.
D-quercitol(8): colorless powder, ESI-MS: [M-H]− 163.4. 13C NMR:
69.0 C-1; 74.6 C-2; 71.1 C-3; 72.3 C-4; 68.6 C-5; 33.4 C-6. 1H
NMR(300 MHz; D2O): 3.82 (m)H-1; 3.61 (t, J = 9.4 Hz) H-2; 3.82 (m)
H-3; 3.98 (t, J = 3.1 Hz) H-4; 4.03 (t, J = 3.1 Hz) H-5; 1.88 (ddd; J =
3.0; 0.7; 13); 2.03 (dt, J = 2.6; 10.3) H-6.
EntilinC(9):Whitepowder,HRESI-MS: [M+Na]+511.2 (calculated
for C27H36O8, 488.24102). 1HNMR(300MHz, CDCl3): 3.76 (1H;d;1.7)H-
3; 5.28 (1H, t, 1.6) H-5; 1,87; 1,97 (2H; t)H-11; 1.48 (2H, m)H-12; 2.03
(1H, t, 3.3) H-14; 1,91; 2.00 (2H, t)H-15; 5.50 (H, s)H-17 0.79 (3H, s)H-
18; 1.83 (3H, s, 1.5) H-19; 7.33 (1H, s)H-21; 6.33 (1H, d, 1.8) H-22; 7.40
(1H, d, 1.70) H-23; 1.07 (3H, s)H-28; 1.16 (3H, s)H-29; 4.60 (1H, s)H-
30; 1.91 (1H,m)H-2′; 1.01 (3H, d, 7.0) H-3′; 1.03 (3H, d; 7.0) H-4′; 3.59
(1H, s)1-OH; 2.93 (1H, s)2-OH; 3.42 (3H, s)9-OMe.
Entilin A(10): White powder, HRESI-MS: [M + Na]+ 488,24,102
(calculated for C28H44O8, 414.33932) 13C NMR(75 MHz, CDCl3): 98.8
C-1; 76.7 C-2; 81.0 C-3; 38.1 C-4; 133.8 C-5; 79.7 C-8; 97.6 C-9; 127.6
C-10; 30.9 C-11; 32.2 C-12; 35.4 C-13; 38.3 C-14; 22.6 C-15; 72.7 C-
17; 24.5 C-18; 16.5 C-19; 124.4 C-20; 139.5 C-21; 10.6 C-22; 143.5 C-
23; 27.8 C-28; 27.9 C-29; 30.9 C-30; 38.8 C-1′; 16.9 C-2′; 17.0 C-4′. 1H
NMR(300 MHz, CDCl3): 3.76 (1H; d;1.7) H-3; 5,23 (1H; t; 1,6) H-5;
1,87; 1,97 (2H; t)H-11; 1.48 (2H, m)H-12; 2.03 (1H, t, 3.3) H-14; 1,91;
2.00 (2H, t)H-15; 0.79 (3H, s)H-18; 1.83 (3H, s, 1,5) H-19; 7.28 (1H, s)
H-21; 6.29 (1H, dd, 1.8) H-22; 7.35 (1H, d, 1.71) H-23; 1.07 (3H, s)H-
28; 1.16 (3H, s)H-29; 4.60 (1H, s)H-30; 1.91 (1H, m)H-2′; 1.01 (3H, d,
7,0) H-3′; 1.03 (3H, d; 7.0) H-4′; 3.59 (1H, s)1-OH; 2.93 (1H, s)2-OH;
3.28 (1H, s)9-OH.
Antrocarine A(11): White powder, ESI-MS: [M + Na]+ 451.4 (cal-
culated for C29H48O2) 13C NMR(75 MHz, CDCl3): 37.1 C-1; 31.4 C-2;
42.1 C-3; 123.9 C-4; 146.3 C-5; 65.4 C-6; 71.4 C-7; 37.6 C-8; 42.3 C-9;
37.4 C-10; 20.8 C-11; 39.2 C-12; 42.2 C-13; 49.5 C-14; 24.3 C-15; 28.3
C-16; 55.7 C-17; 11.7 C-18; 18.3 C-19; 35.8 C-20; 18.8 C-21; 24.8 C-
22; 30.9 C-23; 156.9 C-24; 33.8 C-25; 22.0 C-26; 21.9 C-27; 106.6 C-
28. 1H NMR(300 MHz, CDCl3) (σ (ppm), m, J(Hz)): 1.51, 1.91 (2H, t)
H-1; 1.85, 1.93 (2H q)H-2; 2.32, 2.42(2H, m)H-3; 5.65, (1H, dd, (8,
5.4)) H-4; 3.91 (s, br) H-6; 3.91 (1H, d)H-6; 3.62 (1H, m)H-7 1.17
(1H, t)H-8; 1.35 (1H, t) H-9; 1.54; 1.61 (2H, q) H-11; 2.02; 2.1 (2H, t)
H-12; 1.50 (1H, t)H-14; 1.74; 1.83 (2H, q)H-15; 1.38, 1.97 (2H, t)H-
16; 1.26 (1H, t)H-17; 0.73 (3H, s)H-18; 1.05 (3H, s)H-19; 1.58 (1H, q)
H-20; 0.99 (3H, d, 6.6) H-21; 1.65, 2.24) (2H, q)H-22; 2.13, 2.21(1H,
d)H-23; 2.31(1H, m)H-25; 1.07 (3H, d, 6.6) H-26; 1.05 (3H, d, 6.6) H-
27; 4.71; 4.78 (2H, d, 1.5) H-28.
7α,20(S)-dihydroxy-4,24(28)-ergostadien-3-one(12): white pow-
der, ESI-MS: [M + Na + 2H] +m/z = 437.3 (calculated for C28H44O2
(413.3407)) 13C NMR(75 MHz, CDCl3): 35.3 C-1; 33.8C-2; 199.0 C-3;
127.8 C-4; 168.1 C-5; 41.0 C-6; 68.5 C-7; 39.0 C-8; 44.9 C-9; 38.4 C-
10; 20.6 C-11; 39.5 C-12; 42.6 C-13; 50.5.5 C-14; 23.0 C-15;
22.3C-16; 57.7 C-17; 13.4 C-18; 19.9C-19; 75.0 C-20; 26.2 C-21;
42.4 C-22; 23.9 C-23; 156.1C-24; 33.9 C-25; 21.9 C-26; 21.9 C-27;
106.2 C-28. 1H NMR(300 MHz, CDCl3) (σ (ppm), m, J(Hz)): 1.75;
2.02, (2H, t), H-1; (2.36 (2H, q)H-2; 5.77, (1H, s)H-4; 2.40, 2,60
(1H, m)H-6; 3.95 (1H, q, 3.1) H-7; 1.55 (1H, m)H-8; 1.44 (1H, m)
H-9; 1.44; 1.55(2H, m)H-11; 2.00 (2H, m)H-12; 1.36 (1H, m)H-14;
1.69 (2H, m)H-15; 1.90; 1.30 (2H, m)H-16; 1.118 (1H, m)H-17;
0.69 (3H,s) H-18; 1.27 (3H, s)H-19; 1.40 (1H, m)H-20; 0.93 (3H, d,
6.2) H-21; 1.15, 1.52(2H, m)H-22; 2.06, 1.87 (2H, m)H-23; 2.20
(1H, m)H-25; 1.00 (3H, d, 6.9) H-26; 0.99 (3H, d, 6.9) H-27; 4.69
4.78 (2H, d, 1.5) H-28.
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[M + Na + 2H] +m/z= 599.4 (calculated for C35H60O6Na (599.4255)
13C NMR(75 MHz, CDCl3): 38. 5 C-1; 33.5 C-2; 77.1 C-3; 37.0 C-4;
140.5 C-5; 121.3 C-6; 31.5 C-7; 31.6 C-8; 49.8 C-9; 36.4 C-10; 22.7 C-
11; 41.9 C-12; 42.0 C-13; 56.2 C-14; 25.0 C-15; 28.8 C-16; 55.5 C-17;
11.8 C-18; 19.3 C-19; 35.6 C-20; 18.8 C-21; 138.1 C-22; 129.0 C-23;
50.7 C-24; 24.0 C-25; 12.0 C-26; 29.4 C-27; 20.7 C-28; 100.9 C-1′; 73.5
C-2′; 77.1 C-3′; 70.2 C-4′; 76.9 C-5′; 61.2 C-6′. 1H NMR(300 MHz,
CDCl3) (σ (ppm), m, J(Hz)): 1.24 (2H, m)H-1; (1.39 (2H, m)H-2; 1.93
(2H, dd) H-4; 5.32 (1H, dd) H-6; 1.80 (2H, m)H-7;) 1.50 (1H, m)H-8;
1.50 (1H, m)H-9; 1.50(2H, m)H-11; 1.50 (2H, m)H-12; 1.15 (1H, m)
H-14; 1.80 (2H, m)H-15; 1.80 (2H, m)H-16; 1.24(1H) H-17; 0.82 (3H,
s) H-18; 0.95 (3H, s)H-19; 2.12 (1H, dd) H-20; 0.90 (3H, d)H-21; 5.16
(1H, d)H-22; 5.03 (1H, m)H-23; 1.15 (2H, m)H-25; 1.50 (3H, H-26;
1.63 (1H, m)H-27; 0.76 (3H, dd) H-28; 0.99 (3H, d)H-29; 4.22 (d)H-
1′; 2.90 (m)H-2′; 3.12 (m)H-3′; 3.06 (dd) H-4′; 3.02 (dd) H-5′; 3.64
(dd) H-6′ 4.86 (t)2’-OH; 4.89 (d)3’-OH; 4.86 (t)4’-OH; 4.42 (t)6’-OH.
2.5. Antiplasmodial activity
Activity against Plasmodium falciparumchloroquine-sensitive 3D7
strain was assessed following a procedure already described
(Desjardins et al., 1979). Malaria parasites were maintained in RPMI
1640 medium containing 2 mM L-glutamine and 25 mM Hepes
(Lonza). The medium was further supplemented with 5% Albumax
II,20 mM glucose, 0.65 mM hypoxanthine, 60 μg/mL gentamycin and
2–4% hematocrit human red blood cells. The parasites were cultured
at 37 °C under an atmosphere of 5% CO2, 5% O2, 90% N2 in sealed T25
or T75 culture ﬂasks. For screening samples against malaria parasites,
a compound or natural extract was added to parasite cultures in 96-
well plates and incubated for 48 h in a 37 °C CO2 incubator. After 48 h,
the culture plates were taken out from the incubator. Then, 20 μL of cul-
ture were removed from each well and mixed in a fresh 96-well plate
with 125 μL of a mixture of Malstat solution and NBT/PES solution.
The parasite lactate dehydrogenase (pLDH) activity was measured in
these solutions. A purple product was formed when pLDH was present,
and this product could be quantiﬁed by absorbance at 620 nm (Abs620).
The Abs620 reading in each well was thus an indication of the pLDH ac-
tivity and thereby of the number of parasites in the well.
2.6. Antitrypanosomal activity
To assess antitrypanocidal activity, invitro cultures of Trypanosoma
brucei brucei in 96-well plates were carried out. After an incubation pe-
riod of 48 h, the number of parasites survivingdrug exposurewas deter-
mined by adding a resazurin-based reagent. Resazurin is reduced to
resoruﬁn by living cells. Resoruﬁn is a ﬂuorophore (Excitation560/Emis-
sion590) and can be quantiﬁed in amulti-well ﬂuorescence plate reader.
2.7. HIV-1 integrase strand transfer reaction assay
The HIV-1 subtype C integrase (CIN) strand transfer inhibition assay
was adapted from a previously describedmethod (Grobler et al., 2002).
Brieﬂy, 20 nM double-stranded biotinylated donor DNA (5′-5 Biotin
TEG/ACCCTTTTAGTCAGTGTGGAAAATCTCTAGCA-3′ annealed to 5′-
ACTGCTAGAGATTTTCCACACTGACTAAAAG-3′) was immobilized in
streptavidin coated 96-well microtiter plates (R&D Systems, USA). Fol-
lowing incubation at room temperature for 40 min and, as stringent
wash step, 5 μg/mL puriﬁed recombinant HIV-1CIN in buffer 1 (50 mm
NaCl, 25 mM Hepes, 25 mMMnCl2, 5 mM β-mercaptoethanol, 50 μg/
mL BSA,pH 7.5) was added to individual wells. Recombinant HIV-1CIN
was assembled onto the pre-processed donor DNA through incubation
for 45 min at room temperature. Strand transfer reaction was initiated
through the addition of 10 nM (ﬁnal concentration) double-
strandedFITC-labeled target DNA (5′-TGACCAAGGGCTAATTCACT/36-
FAM/−3′ annealed to 5′-AGTGAATTAGCCCTTGGTCA−/36-FAM/−3′)in integrase buffer 2 (same as buffer 1, except 25 mmMnCl2 replaced
with 2.5 mmMgCl2). After an incubation period of 60 min at 37 °C, the
plates were washed using PBS containing 0.05% Tween 20 and 0.01%
BSA, followed by the addition of peroxidase-conjugated sheep anti-
FITC antibody (Thermo Scientiﬁc, USA) diluted 1:1000 in the same PBS
buffer. Finally, the plates were washed and peroxidase substrate (Sure
Blue Reserve™, KPL, USA) was added to allow for detection at 620 nm
using a Synergy MX (BioTek®) plate reader. Absorbance values were
converted to percentage of enzyme activity relative to the readings ob-
tained from control wells (enzyme without inhibitor).
2.8. Cytotoxic activity
To assess the overt cytotoxicity, plant samples were incubated for
24 h, at a concentration of 20 μM (for pure compounds) or 25 μg/mL
(for extracts) in 96-well plates containing HeLa cells (human cervix ad-
enocarcinoma), maintained in a culture medium made of Dulbecco's
Modiﬁed Eagle's Medium with 5 mM L-glutamine (Lonza), supple-
mented with 10% fetal bovine serum and antibiotics (penicillin/strepto-
mycin/fungizone – PSF). The number of cells surviving drug exposure
was evaluated using the resazurin based reagent and resoruﬁn ﬂuores-
cence quantiﬁed (Excitation560/Emission590) in a multi-well plate
reader.
2.9. Single concentration screening
The percent of parasitemia, or cell viability, was calculated at a ﬁxed
concentration of 20 μM for isolated compounds or 25 μg/mL for natural
plant extracts. Experiments were performed in triplicate wells and a
standard deviationwas derived. For comparative purposes, chloroquine
(an anti-malarial drug), emetine (which induced cell apoptosis) or
pentamidine (an existing drug used in the treatment of trypanosomia-
sis) were used as positive control drug standards at a concentration of
10 μM for the two ﬁrst drug or of 1 μM in case of pentamidine. Com-
pounds were tested for HIV-1 integrase at a concentration of 20 μM
(pure compounds) and 25 μg/mL (crudes extracts) and chicoric acid
was used as positive control for HIV-1 integrase at a concentration of
20 μM.
2.10. Dose response
The IC50 (50% inhibitory concentration) of tested extract/compound
exhibiting a low percentage viabilitywas determined from the resulting
dose–response curve by non-linear regression using the Prism 5 pro-
gram (Version 5.02, graph Pad Software, Inc). Chloroquine and pentam-
idine were used as drug standards according to the type of test
performed. IC50 values for cytotoxicity were not determined due to
the low inhibition observed by the preliminary single concentration
screening (see Results). Extracts and isolated compounds were tested
in a concentration range from 100 to 0.045 μg/mL or μM respectively
using 3-fold serial dilutions for antiplasmodial tests and from 100 to
0.00001 μg/mL or μM respectively, with 10-fold serial dilutions for
antitrypanosomal assays.
3. Results and discussion
3.1. Phytochemistry study
The different crude extracts of D.conocarpa (EDCR, EDCF and EDCTr)
were extracted by silica gel column chromatography and preparative
TLC, resulting in the isolation and characterization of eight pure com-
pounds: mangiferolic acid (1), 3β,22(R)-dihydroxycycloart-24E-en-
26-oic acid (2) (Anjaneyulu et al., 1999), lupeol (3) (Prachayasittikul
et al., 2010), aridanin (4) (Adesina and Reisch, 1985), betulin (5)
(Prachayasittikul et al., 2010), betulinic acid (6) (Yili et al., 2009),
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Fig. 1. Chemical structures of compounds isolated from leaves, stems, and roots of D.conocarpa.
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Rao et al., 2014) (Fig. 1).
The n-hexane/ethyl acetate (1:1) fraction (AKETF1), obtained
by chromatography on the crude extract of A.klaineanum trunk bark,
was separated by chromatography on silica gel column and thin-layer
plates. Six pure compounds were isolated and identiﬁed, namely
entilin C(9) (Daniewski et al., 1994), entilin A(10) (Tchouankeu et al.,
1990), betulinic acid (6) (Yili et al., 2009), antrocarine A(11) (Douanla
et al., 2015), 7α,20(S)-dihydroxy-4,24(28)-ergostadien-3-one (12)
(Tchouankeu et al., 1996) and β-sitosterol glucoside (13) (Yili et al.,
2009) (Fig. 2).OH
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Fig. 2. Chemical structures of compounds iso3.2. Antiplasmodial activity
The two crude extracts of A.klaineanum [AKET (crude extract of
trunk bark of A.klaineanum) and AKER (crude extract of stem bark of
A.klaineanum)] did not reduce signiﬁcantly the viability of the parasite
whereas AKERF1 [hexane/EtOAc (1:1) fraction of crude extract of root
bark of A.klaineanum] and AKETF1 [hexane/EtOAc (1:1) fraction of
crude extract of trunk bark of A.klaineanum] fractions showed the best
antiplasmodial activities with IC50 values of 0.44 and 4.43 μg/mL, re-
spectively, compared with chloroquine which was used here as a drug
reference (IC500.009 μM). No pure compounds signiﬁcantly reducedO
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crude extracts could be due to the presence of compounds having an-
tagonistic effects, while the antiplasmodial activity of fractions
AKERF1 and AKETF1 suggests that the compounds contained in these
fractionsmight be acting in synergy (Chithambo et al., 2017). In another
study, the crude extract of A.klaineanum stem bark also showedmoder-
ate antiplasmodial activity with an IC50 value of 16.7 μg/mL on the 3D7
P.falciparum strains (Douanla et al., 2015).
For crude extracts, IC50 values below 100 μg/mL were proposed as
endpoint criteria in anti-infective assays (Cos et al., 2006), although
the most promising antimalarial extracts exhibit IC50 values under 10
μg/mL (Soh and Benoit-Vical, 2007; Krettli, 2009). Hence, as the hex-
ane/EtOAc (1:1) fraction AKERF1 exhibited an IC50 value lower than 1
μg/mL against P.falciparum, this fraction represented undoubtedly a
good candidate for further bioassay-guided fractionation. Finally,
taken together, all the results support the use of the bark of A.
klaineanum in traditional medicines for treating malaria (Matig et al.,
2006; Betti and Lejoly, 2010; Douanla et al., 2015).
The crude extracts of D.conocarpa roots and trunk [EDCR (crude
extract of roots of Diospyros conocarpa) and EDCTr (crude extract of
trunk of Diospyros conocarpa)], as well as the isolated compounds,
showed lowactivities against P.falciparum strainswith viability percent-
ages (PVs) consistently greater than 90%. This is in contrast with the
ethyl acetate extract of Diospyros hispida roots which displayed growth
inhibitory activity with an IC50 value of 1 μg/mL against P.falciparum(-
Albernaz et al., 2010). According to the literature, the roots, barks, heart-
wood and stems of some Diospyros species are used in traditional
medicine to treat malaria (Kantamreddi and Wright, 2008; Mohamed
et al., 2009; Prachayasittikul et al., 2010) but no antimalarial activityTable 1
In vitro assays of the extracts and compounds.
Sample Antimalarial activ
Name Code PV (%)
Extract
Crude extract of trunk bark of AK AKET 132.28 ± 18.06
Crude extract of roots bark of AK AKER 82.57 ± 4.48
Crude extract of roots of DC EDCR 90.49 ± 5.64
Crude extract of Trunk of DC EDCTr 90.81 ± 2.72
Hexane/EtOAc (1:1) fraction of AKET AKETF1 −5.41 ± 2.13
Hexane/EtOAc (1:1) fraction of AKER AKERF1 −13.61 ± 3.01
Compound
Mangiferonic acid 1 90.72 ± 5.73
3β, 22(R ou S)-dihydroxycycloart 24E-en-26-oic acid 2 82.24 ± 17.11
Lupeol 3 108.93 ± 10.00
Aridanin 4 80.40 ± 5.88
Betulin 5 105.01 ± 8.71
Betulinic acid 6 100.48 ± 10.57
Bergenin 7 101.15 ± 0.78
D-quercitol 8 101.54 ± 7.34
Entiline C 9 106.60 ± 1.83
Entiline A 10 117.98 ± 0.29
Antrocarine A 11 120.02 ± 7.89
7R, 20(S)-dihydroxy-4,24(28)-ergostadien-3-one 12 123.84 ± 9.51
Stigmasterol glucosid 13 113.13 ± 7.24
References
Chloroquine −5.60
Pentamidine
Emetine
Chicoric acid
PV values are from two replicate experiments 20 μM (pure compound) or 25 μg/mL (plant ext
AK: Antrocaryon klaineanum, DC: Diospyros conocarpa, nd: not determined;
PV: percentage viability;
IC50: 50% inhibitory concentration, i.e. the concentration of extract/compound that reduces by 50
compounds and reference drugs.
a P.falciparum 3D7 strain;
b T.brucei brucei strain trypomastigotes;
c HeLa (human cervix adenocarcinoma) cells;
d HIV-1 integrase inhibitory activity;has yet been reported for D.conocarpa. Due to the low level of activity,
its traditional use as antimalarial might not be ascribed to the extracts
tested in our study.
3.3. Antitrypanosomal activity
According to the traditional pharmacopeia, the trunk bark of A.
klaineanum has antiparasitic activity. Besides the antiplasmodial activity
described in the previous section, we proposed to assay the
antitrypanosomal activity of this plant, in particular as some related
species, such as Magnifera indica and Spondias mombim, exhibit
antitrypanosomal effects (Nwodo et al., 2015).
The results showed that the three crude extracts, AKER,AKET and
EDCTr, as well as the fraction AKERF1, exhibited moderate activities,
with PVs of 26.75, 43.96, 52.42 and 4.48, respectively (Table 1). The frac-
tion AKETF1 displayed an antitrypanosomal activity with an IC50 value
between 10 and 1 μg/mL. Aridanin (4) and antrocarine A(11) exhibited
trypanocidal activities on the T.b. brucei strain with IC50 values of 10–1
and 8.9 μM, respectively.
The two crude extracts, AKER and AKET, were less active than their
related fractions AKERF1 and AKETF1. This could be due to the presence
of compounds having antagonistic effects (Zhu et al., 1997). However,
the strong activity of the antrocarine A(11), which is the major com-
pound isolated from the fraction AKETF1, sustains the trypanocidal ef-
fect of this latter fraction (Table 1). The antitrypanosomal activity of
aridanin (4) (PV = 0.59 ± 0.08) was comparable to that of the extract
EDCR (PV = 1.04 ± 0.18), from which the compound was extracted
(Table 1). These results conﬁrm the use of the plant extracts ofDiospyros
genus in the treatment of parasitic diseases, more especially thoseitya Antitrypanosomal
activityb
Cytotoxic activityc HIV-1 CIN
activityd
IC50 PV (%) IC50 PV (%) IC50 % Activity IC50
nd 43.96 ± 7.97 nd 90.30 ± 12.74 nd 38.87 17.39
nd 26.75 ± 3.82 nd 100.32 ± 2. 08 nd −43.90 1.96
nd 1.04 ± 0.18 nd 95.60 ± 13.59 nd 105.64 nd
nd 52.42 ± 8.20 nd 48.50 ± 8.88 nd 43.14 24.04
4.43 2.15 ± 0.48 10–1 61.60 ± 7.04 nd −26.98 3.60
0.44 4.48 ± 0.67 nd 88.85 ± 3.61 nd −18.45 35.08
nd 98.48 ± 9.31 nd 87.65 ± 4.88 nd 126.98 nd
nd 53.48 ± 4.22 nd 78.53 ± 12.19 nd 220.88 nd
nd 51.32 ± 7.36 nd 88.48 ± 2.43 nd 96.95
nd 0.59 ± 0.08 10–1 76.04 ± 3.58 nd 85.52 18.32
nd 58.86 ± 10.75 nd
nd 93.68 ± 3.40 nd 73.92 ± 0.30 nd 14.02 nd
nd 98.36 ± 4.27 nd 68.00 ± 16.15 nd 158.23 nd
nd 95.77 ± 7.87 nd 82.72 ± 13.48 nd 257.32 nd
nd 103.92 ± 7.53 nd 83.50 ± 7.09 nd 174.24 nd
nd 36.61 ± 0.22 nd 83.53 ± 3.43 nd 253.81 nd
nd 2.29 ± 0.18 8.92 97.33 ± 0.21 nd 207.47 nd
nd 95.36 ± 3.56 nd 104.22 ± 0.30 nd 143.75 nd
nd 72.41 ± 6.27 nd 81.12 ± 8.10 nd 59.15 nd
0.0089
0.00078
0.044
−51.37 0.008
ract);
% the growth or proliferation of cells in μg/mL for extracts and fractions, and in μM for pure
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1998; Bizimana et al., 2006; Norhayati et al., 2013).
3.4. Cytotoxic activity
The crude extracts, some fractions and the pure compounds were
tested against HeLa cells. As the percentages of cell viability remained
high (N48%) for all tested samples, the IC50 values were not assessed.
Hence, all the samples were non-cytotoxic against HeLa cervical cancer
cells.
3.5. HIV-1 Integrase inhibitory activity
The results showed that all crude extracts except EDCR exhibited
moderate HIV-1IN inhibitory activity with IC50 values of 24.04, 17.39
and 1.96 μg/mL for EDCTr, AKET and AKER, respectively (Table 1). The
fractions AKERF1 and AKETF1 also displayed amoderate HIV-1IN inhib-
itory actionwith IC50 values of 35.08 and 3.60 μg/mL, respectively, com-
pared with chicoric acid taken as a reference drug (IC500.008 μM).
Among the pure compounds tested, only aridanin (4) presented amod-
erate activity with an IC50 of 18.32 μM (Table 1).
According to phytochemical screening studies, the A.klaineanum
methanol extract contains steroids, ﬂavonoids, tannins and phenolic
compounds (Sima et al., 2015; Fongang et al., 2017). Some Anarcadiaceae
species, such as Spondias speciosa, Mangifera indica and Rhuspar viﬂora,
exhibited anti-HIV-1 effects (Guha et al., 1996; Sahar et al., 2009; Modi
et al., 2013).
The HIV-1 inhibitory activity observed for aridanin (4) (IC5018.32
μM) corroborated the effects of the EDCTr extract (IC5024.04 μg/mL).
However, the crude extract of D.Conocarpa roots (EDCR) exhibited no
signiﬁcant activity with a PV of 105.64. The same trend was observed
for lupeol (3), betulin (5) and betulinic acid (6) with PV of 96.95,
95.58 and 85.52, respectively. These later compounds are pentacyclic
triterpenes belonging to the lupane serie. According to the literature,
betulinic acid and its derivatives have been reported to inhibit HIV-1
entry and replication, HIV protease or the HIV reverse transcriptase
(Fujioka and Kashiwanda, 1994; Mayaux et al., 1994; Pengsuparp et
al., 1994; Xu et al., 1996; Dzubak et al., 2006). HIV-1IN inhibitory activ-
ities were reported for the wood of D.decandra, the bark of D.rhodocalyx
Kurz, the leaves of D.chloroxylon Roxb. and D.Montana Roxb. (Sahar et
al., 2009; Bunluepuech and Tewtrakul, 2009, 2011). Such activity was
found here for the ﬁrst time in plant extracts of D.conocarpa and A.
klaineanum.
4. Conclusion
The invitro antimalarial, antitrypanosomal and HIV-1 inhibitory
integrase activities were assessed for different extracts of two
Cameroonian plants. Interestingly, the performed extractions led to
the isolation and the identiﬁcation of 13 different chemical compounds
that were additionally tested for their invitro activities. Although all
these compounds have already been isolated from other plants, we
clearly established here their presence in the different extracts of A.
klaineanum and D.conocarpa.
The A.klaineanum hexane/EtOAc (1:1) fractions of root and trunk
barks, AKERF1 and AKETF1, showed the best antiplasmodial activities
whereas on the contrary the corresponding crude extracts did not sig-
niﬁcantly decrease the viability of the parasite P.falciparum. The pres-
ence of chemicals with antagonistic effects in crude extracts could
explain these results. In marked contrast, it was found that D.conocarpa
extracts of roots and trunk, as well as all isolated compounds, had only
little effects against P.falciparum growth. Therefore, the observed activ-
ities of AKERF1 and AKETF1 could result from synergetic action of
chemicals or phytocomplexes present in these fractions. Furthermore,
according our results the traditional use D.conocarpa as antimalarialwould not be assigned to the two plant parts tested, but more likely to
other parts of the plant.
The crude extract EDCR of D.conocarpa, fractions AKERF1 and
AKETF1, as well as isolated compounds aridanin (4) and antrocarine
A(11), all presentedmoderate trypanocidal activity, conﬁrming thereby
the antiprotozoal potential of Antrocaryon and Diospyros genus. In addi-
tion, the comparison between the parasiticidal and cytotoxicity effects
suggests that the decrease in viability of parasites may not be caused
by a general cytotoxicity of the tested extracts. Concerning the anti-
HIV potential of the plants, it is worthy of note that the AKER and
AKETF1 fractions of A.klaineanum exhibited attractive inhibitory activity
against HIV integrase. Finally, further studies are therefore necessary to
determine putative new antiplasmodial, antitrypanosomal and/or anti-
HIV agents for drug preparation.Competing interest
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